Insider Trading & Ownership of New Enterprise Associates 16, L.P.

Location
1954 Greenspring Drive, Suite 600, Timonium, MD
Summary
The estimated value of insider holdings of New Enterprise Associates 16, L.P. is at least $88.7M dollars as of October 6, 2025. New Enterprise Associates 16, L.P. is the 10%+ Owner of Mirum Pharmaceuticals, Inc. and owns shares of Mirum Pharmaceuticals, Inc. (MIRM) stock worth about $61.3M. New Enterprise Associates 16, L.P. is the 10%+ Owner of Trevi Therapeutics, Inc. and owns shares of Trevi Therapeutics, Inc. (TRVI) stock worth about $21.1M. New Enterprise Associates 16, L.P. is the 10%+ Owner of Marker Therapeutics, Inc. and owns shares of Marker Therapeutics, Inc. (MRKR) stock worth about $5.2M. New Enterprise Associates 16, L.P. is the 10%+ Owner of Metacrine, Inc. and owns shares of Metacrine, Inc. stock worth about $1.2M.
Signature
/s/ Zachary Bambach, attorney-in-fact
All Insider Reports
All Insider Reports

Notify me when New Enterprise Associates 16, L.P. files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of New Enterprise Associates 16, L.P.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
MIRM Mirum Pharmaceuticals, Inc. 10%+ Owner $61.3M Jun 13, 2023
TRVI Trevi Therapeutics, Inc. 10%+ Owner $21.1M Apr 11, 2022
MRKR Marker Therapeutics, Inc. 10%+ Owner $5.2M +$1.77M +51.7% Dec 23, 2024
MTCR Metacrine, Inc. 10%+ Owner $1.2M Dec 10, 2021
NEUE NeueHealth, Inc. Director, 10%+ Owner $0 -$1.89K -100% Oct 2, 2025
AKUS Akouos, Inc. 10%+ Owner Nov 30, 2022
GNCA GENOCEA BIOSCIENCES, INC. 10%+ Owner May 24, 2022

Insider Transactions Reported by New Enterprise Associates 16, L.P.:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.